Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: A randomized, double blinded, placebo controlled crossover trial in the UV-B pain model
Thomas Sycha*, Sebastian Anzenhofer, Stephan Lehr, Leopold Schmetterer, Boris Chizh, Hans Georg Eichler, Burkhard Gustorff
Research output: Contribution to journal › Article › peer-review
58Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: A randomized, double blinded, placebo controlled crossover trial in the UV-B pain model'. Together they form a unique fingerprint.